Correlation between thyroidal and peripheral blood total T cells, CD8⁺ T cells, and CD8⁺ T- regulatory cells and T-cell reactivity to calsequestrin and collagen XIII in patients with Graves’ ophthalmopathy

References

• Lazarus JH. Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease. Best Practice Res Clin Endocrinol Metab. 2012;26(3):273–279.
   PubMed Web of Science ®Google Scholar
• Tjiang H, Lahooti H, McCorquodale T, Parmar KR, Wall JR. Eye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditis. Thyroid. 2010;20(3):287–290.
   PubMed Web of Science ®Google Scholar
• Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. Thyroid-associated ophthalmopathy–a model for the association of organ-specific autoimmune disorders. Immunol Today. 1991;12(5):150–153.
   PubMedGoogle Scholar
• Wall JR, Bernard N, Boucher A, et al. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves’ hyperthyroidism and Hashimoto’s thyroiditis. Clin Immunol Immunopathol. 1993;68(1):1–8. doi:10.1006/clin.1993.1087.
   PubMedGoogle Scholar
• Weightman D, Kendall-Taylor P. Cross-reaction of eye muscle antibodies with thyroid tissue in thyroid-associated ophthalmopathy. J Endocrinol. 1989;122(1):201–206.
   PubMed Web of Science ®Google Scholar
• Eckstein AK, Plicht M, Lax H, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab. 2006;91(9):3464–3470. doi:10.1210/jc.2005-2813.
   PubMed Web of Science ®Google Scholar
• Paschke R, Vassart G, Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf). 1995;42(6):565–569.
   PubMed Web of Science ®Google Scholar
• Bahn RS. Clinical review 157: pathophysiology of Graves’ ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 2003;88(5):1939–1946.
   PubMed Web of Science ®Google Scholar
• Gunji K, De Bellis A, Kubota S, et al. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves’ hyperthyroidism. J Clin Endocrinol Metab. 1999;84(4):1255–1262.
   PubMed Web of Science ®Google Scholar
• Salvi M, Miller A, Wall JR. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 1988;232(1):135–139.
   PubMed Web of Science ®Google Scholar
• Wescombe L, Lahooti H, Gopinath B, Wall JR. The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves’ ophthalmopathy–support for a role of autoimmunity against calsequestrin as the triggering event. Clin Endocrinol (Oxf). 2010;73(4):522–528.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Musselman R, Beard N, et al. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves’ disease. Clin Exp Immunol. 2006;145(1):56–62. doi:10.1111/j.1365-2249.2006.03110.x.
   PubMed Web of Science ®Google Scholar
• Heufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves’ ophthalmopathy. Eur J Clin Invest. 1993;23(1):10–17.
   PubMed Web of Science ®Google Scholar
• Weetman AP, Cohen S, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves’ ophthalmopathy. Clin Exp Immunol. 1989;75(2):222–227.
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves’ ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest. 1994;93(6):2738–2743.
   PubMed Web of Science ®Google Scholar
• Pappa A, Calder V, Ajjan R, et al. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol. 1997;109(2):362–369. doi:10.1046/j.1365-2249.1997.4491347.x.
   PubMed Web of Science ®Google Scholar
• Filaci G, Fravega M, Negrini S, et al. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol. 2004;65(2):142–156. doi:10.1016/j.humimm.2003.12.001.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Konya C, Goronzy JJ, Weyand CM. Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol. 2008;69(11):781–789.
   PubMed Web of Science ®Google Scholar
• Forster G, Otto E, Hansen C, Ochs K, Kahaly G. Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol. 1998;112(3):427–434.
   PubMed Web of Science ®Google Scholar
• Pappa A, Lawson JM, Calder V, Fells P, Lightman S. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol. 2000;84(5):517–522.
   PubMed Web of Science ®Google Scholar
• Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev. 2005;4(5):315–321.
   PubMed Web of Science ®Google Scholar
• Afanasyeva M, Georgakopoulos D, Rose NR. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev. 2004;3(7–8):476–486.
   PubMed Web of Science ®Google Scholar
• Grabie N, Delfs MW, Westrich JR, et al. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest. 2003;111(5):671–680. doi:10.1172/JCI200316867.
   PubMed Web of Science ®Google Scholar
• Tada Y, Ho A, Koh DR, Mak TW. Collagen-induced arthritis in CD4- or CD8- deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol. 1996;156(11):4520–4526.
   PubMed Web of Science ®Google Scholar
• Uchimura K, Itoh M, Yamamoto K, et al. The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves’ disease: the role of CD8+ cells. Clin Exp Immunol. 2002;128(2):308–312. doi:10.1046/j.1365-2249.2002.01818.x.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhong W, Lu X, et al. Association of Graves’ disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol. 2008;28(5):464–472. doi:10.1007/s10875-008-9213-4.
   PubMed Web of Science ®Google Scholar
• De Haan S, Lahooti H, Morris O, Wall JR. Epitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye disease. Autoimmunity. 2010;43(8):698–703.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Wescombe L, Nguyen B, Wall JR. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease? Orbit. 2009;28(4):256–261.
   PubMedGoogle Scholar
• De Bellis A, Sansone D, Coronella C, et al. Serum antibodies to collagen XIII: a further good marker of active Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 2005;62(1):24–29. doi:10.1111/j.1365-2265.2004.02167.x.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Adams CL, Musselman R, Tani J, Wall JR. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul Immunol Inflamm. 2007;15(2):81–88.
   PubMed Web of Science ®Google Scholar